๐Ÿงช Lab Test (Platelet count / PLT) ๐Ÿงซ Whole blood (venous) โ€” EDTA anticoagulated (lavender top)

Platelet Count: Nursing Guide

Platelet count reports how many clotting cells circulate in the blood โ€” a number nurses trend with bruising, mucosal bleeding, and procedure safety. Low counts support thrombocytopenia workups; high counts may reflect inflammation or marrow disorders โ€” always read platelets with symptoms, medicines, and complete blood count (CBC) context, not one value alone.

14 min read
Updated June 20, 2026
Medically Reviewed

Quick Facts

Category
Platelet count
Specimen
EDTA whole blood
Main nursing risk
Missing critical thrombocytopenia with bleeding or treating spurious
Turnaround
Often same-day

Key Takeaway

Platelets help blood clot โ€” low counts raise bleeding risk while high counts may reflect inflammation or marrow problems.

Specimen & Collection Details

Nurse quick-reference for collection prep that affects result quality.

Tube / container

Lavender or purple EDTA hematology tube per institutional protocol

EDTA anticoagulant โ€” verify lavender-top tube type and fill volume per phlebotomy policy; platelet count is commonly part of a complete blood count on the same specimen

Specimen type

Whole blood (venous) โ€” EDTA anticoagulated (lavender top)

Volume required

Typically one lavender-top venous sample โ€” volume per institutional phlebotomy protocol

Collection timing

Routine or stat timing for bleeding, cytopenia surveillance, preprocedure checks, or chemotherapy monitoring โ€” often paired with other CBC components on one draw

Fasting required

you usually do not need special preparations for a platelet count test alone โ€” confirm with the ordering clinician when other fasting labs are paired on the same draw

Transport / storage

Label promptly at bedside; mix gently per policy; transport to hematology laboratory within institutional turnaround requirements; avoid clotting, hemolysis, and prolonged delay

Turnaround time

Often hours to same-day in hospital laboratories โ€” not one universal interval in reviewed references

Lab section

Hematology / complete blood count (CBC) component

What is Platelet Count?

Platelet Count is a blood test that measures the number of platelets in your blood. In practice, platelets are small cell fragments that help blood clot and stop bleeding. The test is often part of a complete blood count and may also be called a thrombocyte count or PLT.

Overview

Nurses see platelet counts on oncology units monitoring chemotherapy, medical wards evaluating petechiae or peripheral blood smear follow-up, and preprocedure pathways assessing bleeding risk. Because platelets reflect clotting capacity, falling counts with mucosal bleeding require urgent review of antiplatelet and anticoagulant medicines during medication reconciliation.

Low platelet counts are called thrombocytopenia; high counts may reflect thrombocytosis when clinical findings support it. Counts below about 50,000 platelets per microliter may carry higher bleeding risk in many references โ€” always apply the reporting laboratory interval and institutional critical-value policy, not one universal threshold. Nurses trend serial PLT with hemoglobin, INR when anticoagulated, and prescriber-directed smear review when results conflict with examination.

Clinical Nursing Focus

Before interpreting platelet count, document petechiae, gum or nose bleeding, melena history, and medicines including aspirin, heparin, and chemotherapy. Compare today’s PLT with prior trends. Reference ranges vary by laboratory and method โ€” use the reporting interval. Escalate critical results, mucosal bleeding, or falling counts with antiplatelet therapy per facility policy.

Thrombocytopenia, Bleeding, and Pseudothrombocytopenia Safety

Platelet count is a fast bleeding-risk signal, yet pseudothrombocytopenia from EDTA clumping, recent transfusion, or antiplatelet medicines can distort how nurses respond. The highest-risk errors are delaying critical-value notification while mucosal bleeding is active, and canceling procedures based on one spurious low count without smear review.

Highest-risk scenarios
  • Critical thrombocytopenia with gum bleeding, petechiae, or falling trend โ€” escalate per protocol regardless of one prior acceptable PLT
  • Chemotherapy patient with declining platelets and aspirin on MAR while mucosal bleeding worsens
  • Unexpectedly low PLT without bleeding โ€” pseudothrombocytopenia not ruled out before major treatment decisions
  • Clotted or mislabeled EDTA specimen driving unsafe procedure clearance or antiplatelet continuation

Document: bleeding signs, PLT trends, antiplatelet and anticoagulant medicines, prescriber notification, precautions implemented, and evaluate outcomes after intervention.

What Platelet Count Can and Cannot Tell You

This test can help identify:

  • Thrombocytopenia patterns when PLT falls with petechiae, gum bleeding, or bruising
  • Thrombocytosis or reactive platelet elevation when clinical context supports it
  • Serial trends during chemotherapy, infection, or preprocedure bleeding-risk review
  • Need for peripheral smear or repeat collection when pseudothrombocytopenia is suspected

This test cannot:

  • Diagnose leukemia, ITP, or marrow failure alone
  • Rule out bleeding because one PLT remains within reference
  • Distinguish true thrombocytopenia from EDTA clumping without smear or recollection
  • Replace coagulation studies, fibrinogen, or specialist hematology when indicated

Pre-draw Checks for Platelet Count and EDTA Specimens

Verify

โœ“Correct patient and platelet count or CBC order with stat timing noted
โœ“Lavender EDTA tube type and fill volume per phlebotomy policy
โœ“Baseline petechiae, gum bleeding, procedure plans, and vital signs
โœ“Antiplatelet, anticoagulant, and chemotherapy medicines documented
โœ“Parallel hemoglobin and CBC components coordinated on one draw when ordered
โœ“Transport plan to hematology laboratory within institutional time limits

Clarify before proceeding when:

  • Critical or falling PLT with mucosal bleeding or petechiae
  • Unexpectedly low count without bleeding โ€” clumping or specimen issue suspected
  • Recent platelet transfusion may temporarily alter trend timing
  • Result conflicts strongly with examination (low PLT, no bleeding signs โ€” consider pseudothrombocytopenia)
  • Specimen clotted, hemolyzed, or collected into wrong tube
  • Duplicate PLT within hours without prescriber indication for serial testing

Reading Platelet Trends With Bleeding Signs and CBC Context

Integrate platelet count with bleeding signs, medicines, hemoglobin, and serial trends. Always apply the reporting laboratory reference interval โ€” Reference intervals are an example adult range of 150,000 to 400,000 platelets per microliter.

Clinical patternPlatelet contextNursing focus
Chemotherapy cytopeniaFalling PLT with petechiae on oncology unitCritical-value pathway; bleeding precautions; antiplatelet review per orders
Mucosal bleedingLow PLT with gum or nose bleedingNotify prescriber; soft toothbrush teaching; hold antiplatelets per order
Preprocedure reviewPLT near lower limit before invasive procedureCommunicate trend to prescriber; confirm hold rules and transfusion pathway
Reactive thrombocytosisHigh PLT after infection or inflammationTrend with clinical recovery; avoid assuming primary marrow disorder alone
โ†” On a small screen, swipe or scroll sideways to see the full table.

Reference ranges, critical values, and protocols may vary by laboratory, institution, patient population, and testing method. Always follow local policy and the reporting laboratory’s reference range.

Platelet Patterns Nurses Recognize

PatternPlatelet contextNursing action
PseudothrombocytopeniaUnexpectedly low automated PLT without bleeding; EDTA clumping suspectedNotify laboratory; request smear or citrate recollection before major holds or transfusion decisions
Educational bleeding-risk tier counts below about 50,000 per mcL may carry higher bleeding risk โ€” not a universal critical valueApply institutional critical policy; do not treat 50K as automatic transfusion threshold without orders
Critical with mucosal bleedingMarkedly low PLT plus gum bleeding or petechiae during chemotherapyCritical-value notification, bleeding precautions, antiplatelet hold per order; evaluate outcomes on repeat count
Reactive thrombocytosisHigh PLT after infection, inflammation, or iron deficiencyTrend with recovery; communicate persistent extreme elevation per orders
โ†” On a small screen, swipe or scroll sideways to see the full table.

EDTA Clumping, Antiplatelet Agents, and Bleeding Traps at the Bedside

Bedside pointNursing note
EDTA clumping trapLow PLT without petechiae โ€” ask laboratory about pseudothrombocytopenia before panic transfusion
Antiplatelet reviewAspirin on MAR with mucosal bleeding needs prescriber communication โ€” do not independently restart or hold
Trend beats snapshotSerial PLT during chemotherapy โ€” one value rarely drives transfusion alone
Bleeding precautionsElectric razor, soft toothbrush, fall precautions when thrombocytopenia and bleeding coexist per orders
50K educational notestandard clinical references bleeding-risk context below about 50,000/mcL is not a substitute for facility critical values
Evaluate outcomesReassess after transfusion or hold โ€” modest PLT rise with ongoing gum bleeding needs prescriber review
โ†” On a small screen, swipe or scroll sideways to see the full table.

Why Platelet Count is Ordered

Platelet count is ordered when clinicians need to assess bleeding risk, screen for thrombocytopenia or thrombocytosis, or monitor marrow-suppressing therapy โ€” integrated with history, examination, and CBC context.

Clinical Indication What the Test Answers Nursing Rationale
Bleeding signs or bruising concern Do low platelets align with petechiae, gum bleeding, or easy bruising? standard clinical references lists bleeding and bruising among reasons to check platelets when interpreted with clinical findings and other CBC components.
Chemotherapy or marrow-suppressing therapy monitoring Are platelets safe for procedures, antiplatelet therapy, or next treatment cycle? Serial platelet counts help track cytopenias during oncology and high-risk medicine pathways โ€” nurses evaluate outcomes with symptoms, not PLT alone.
Suspected thrombocytopenia or marrow disease Does thrombocytopenia fit aplastic anemia or other marrow disorders after ruling out pseudothrombocytopenia? low platelets may result from decreased production, increased destruction, or splenic sequestration โ€” specialist workup may follow, not PLT alone.
Preoperative or routine screening Is baseline platelet count needed before surgery or as part of routine CBC screening? platelet count may be part of routine checkups and preprocedure assessment โ€” nurses communicate abnormal trends with bleeding history per orders.
โ†” On a small screen, swipe or scroll sideways to see the full table.

Contraindications and Precautions

There is no absolute contraindication to venous blood draw for platelet count. Nursing focus is on correct EDTA collection, timely transport, bleeding precautions when indicated, and preventing misinterpretation without trends and smear review when spurious.

When platelet results must not delay urgent care
  • Critical or markedly low platelet value with active mucosal bleeding, petechiae, or hemodynamic change โ€” escalate per facility policy; do not defer prescriber notification while awaiting repeat CBC alone.
  • Falling platelets on antiplatelet or anticoagulant therapy with new bruising or gum bleeding โ€” notify prescriber urgently regardless of whether prior PLT was acceptable.
  • Using a single within-reference platelet count to dismiss chemotherapy-related thrombocytopenia trends or procedure bleeding risk โ€” serial values and examination override isolated snapshots.
Interpretation pitfalls
  • Pseudothrombocytopenia from EDTA-induced platelet clumping may falsely lower count โ€” confirm with smear or recollection in citrate tube per laboratory guidance.
  • Recent transfusion or massive hemorrhage may transiently alter platelet trends โ€” document timing and volume status for interpretation.
  • Clotted, hemolyzed, or underfilled EDTA specimens may yield inaccurate counts โ€” verify collection before major procedure or medicine decisions.
Escalate If
  • Institution-defined critical platelet value or mucosal bleeding with thrombocytopenia โ€” activate critical-value protocol and bleeding precautions per policy.
  • Serial falling platelets during chemotherapy with petechiae or gum bleeding โ€” notify prescriber and support transfusion or hold pathway per orders.
  • Markedly high platelets with stroke symptoms, erythromelalgia, or new thrombosis concern โ€” communicate to prescriber per orders after ruling out reactive causes.

Patient Preparation

Preparation focuses on verifying CBC or platelet order, documenting bleeding symptoms and antiplatelet medicines, and confirming EDTA tube requirements before venipuncture.

Pre-test checks
โœ“Confirm platelet count or CBC order, stat timing, and whether fasting labs are paired on the same draw.
โœ“Review aspirin, P2Y12 inhibitors, heparin, warfarin, and chemotherapy medicines affecting bleeding risk.
โœ“Document petechiae, gum or nose bleeding, melena history, and recent procedures or transfusions.
โœ“Prepare lavender EDTA tube per phlebotomy manual and label before draw.
โœ“Coordinate timing with hemoglobin and other CBC components when ordered on one specimen.
โœ“Explain platelet count reflects clotting cell number interpreted with symptoms โ€” not a diagnosis alone.
Medications to Review or Hold

Review antiplatelet agents, anticoagulants, heparin, chemotherapy, and linezolid or other marrow-suppressing medicines โ€” document for interpretation; do not hold prescribed medicines unless the clinician instructs.

Performance โ€” nursing procedure guide

This page is a Tests & Diagnostics guide for Platelet Count. It emphasizes why the test is ordered, how to interpret results, when to escalate, and preparation factors that affect validity โ€” not step-by-step performance technique (those live under Nursing Procedures when available).

How the test is performed

Step-by-step technique, supplies, infection prevention, and immediate post-procedure monitoring for this test are covered in:

Venipuncture

Use the Patient preparation, Results and interpretation, and Nursing responsibilities sections on this page for order verification, pre-analytic checks, result follow-up, critical-value escalation, and documentation.

Result follow-up at a glance

Nursing workflow on this page โ€” from order to safe action on results:

1
Confirm indication & correct order
2
Coordinate performance per nursing procedure guide (see above)
3
Document pre-analytic preparation & timing
4
Review result with trend & clinical picture
5
Escalate critical or discordant findings
6
Document communication & patient teaching

Results and Interpretation

Platelet count is reported as the number of platelets per microliter of blood (often shown as x10^9/L or thousands per mcL). Interpret using the reporting reference interval, bleeding signs, medicines, and serial trends. Reference intervals are an example adult interval of 150,000 to 400,000 platelets per microliter โ€” ranges vary by laboratory. Reference ranges, critical values, and protocols may vary by laboratory, institution, patient population, and testing method. Always follow local policy and the reporting laboratory’s reference range.

Reference Range Disclaimer

Reference ranges, critical values, and protocols may vary by laboratory, institution, patient population, and testing method. Always follow local policy and the reporting laboratory’s reference range.

Result Range / Finding Clinical Meaning Nursing Action
Within reference interval Within laboratory-specific interval โ€” standard clinical references example 150,000โ€“400,000 platelets per microliter for adults; use the reporting laboratory reference range Platelet count within reference may suggest adequate clotting cell number when clinical findings agree โ€” not a stand-alone rule-out during active bleeding, chemotherapy, or antiplatelet therapy Continue clinical monitoring; avoid false reassurance if petechiae, gum bleeding, or falling trends persist
Borderline / near reference limit Near lower or upper reference limit on reporting laboratory interval Borderline low may support thrombocytopenia monitoring with bleeding assessment; borderline high may reflect reactive thrombocytosis needing clinical correlation Notify prescriber when symptoms or medicines fit; document trend and smear review per orders
High / above reference interval Above laboratory reference interval (thrombocytosis) May reflect inflammation, iron deficiency, splenectomy, or marrow disorders per ASH โ€” requires clinical correlation and often additional testing Communicate to prescriber; assess thrombosis symptoms; avoid labeling primary marrow disorder without specialist review; monitor and evaluate outcomes per orders
Low / below reference interval Below laboratory reference interval (thrombocytopenia) May reflect decreased production, increased destruction, sequestration, or medicines โ€” counts below about 50,000 per mcL may carry higher bleeding risk as educational context, not a universal critical threshold Notify prescriber; implement bleeding precautions when ordered; assess mucosal bleeding; review antiplatelet and anticoagulant medicines; monitor serial PLT trends
โ†” On a small screen, swipe or scroll sideways to see the full table.

Urgent Clinical Escalation and Result Follow-Up

Universal numeric critical-value thresholds for platelet count are Turnaround and screening rules vary by institution; follow local policy standard clinical references, ASH, or standard clinical references. higher bleeding risk may occur below about 50,000 platelets per microliter as educational context โ€” urgent nursing action depends on institutional critical-result policy, mucosal bleeding, petechiae, falling trends, antiplatelet therapy, and vital signs.

Critical Finding Threshold / Value Immediate Action
Critical thrombocytopenia with active bleeding Institution-defined critical PLT or marked thrombocytopenia with gum bleeding, petechiae, or hemodynamic change Escalate according to facility policy; notify prescriber urgently โ€” implement bleeding precautions and review antiplatelet holds per orders
Falling platelets during chemotherapy with new petechiae Serial PLT decline with mucosal bleeding signs while antiplatelet agent remains on MAR Notify prescriber; bleeding precautions; hold aspirin or other antiplatelets per order; evaluate outcomes with repeat count
Suspected pseudothrombocytopenia with conflicting examination Unexpectedly low PLT without bleeding signs โ€” clumping suspected on automated counter Notify laboratory and prescriber; request peripheral smear or recollection per protocol before procedure cancellation alone
โ†” On a small screen, swipe or scroll sideways to see the full table.
Stop and Escalate

Stop routine workflow and escalate according to facility policy when mucosal bleeding is uncontrolled, when critical thrombocytopenia is untreated, or when a clotted or mislabeled specimen would drive unsafe procedure or antiplatelet decisions.

Factors Affecting Results

Platelet count interpretation requires medicine review, serial trends, and awareness of pre-analytic error. Nurses prevent false alarm from pseudothrombocytopenia and false reassurance from one within-reference value during active bleeding risk.

False Positives
  • Spurious thrombocytopenia from EDTA-induced platelet clumping (pseudothrombocytopenia)
  • Platelet satellitism or clumping after difficult venipuncture or delayed mixing
  • Automated counter artifact when giant platelets or fragments are present โ€” smear review may clarify
False Negatives
  • Normal PLT while mucosal bleeding persists on antiplatelet therapy โ€” symptoms trump isolated value
  • Single within-reference count during rapid chemotherapy-related decline โ€” repeat testing needed
  • Recent platelet transfusion temporarily raising count before underlying thrombocytopenia reappears
Interfering Factors
  • Aspirin, P2Y12 inhibitors, heparin, warfarin, and chemotherapy affecting bleeding risk
  • Clotted, hemolyzed, or underfilled EDTA specimen; recent transfusion timing
  • EDTA pseudothrombocytopenia, splenomegaly, or reactive thrombocytosis from inflammation
Test Limitations

Platelet count cannot diagnose thrombocytopenia cause, rule out bleeding, or replace smear review when clumping is suspected. Always use the reporting laboratory reference interval and integrate with examination, medicines, and CBC per ASH guidance.

Nursing Responsibilities

Nursing responsibilities center on safe EDTA collection, timely communication of PLT trends with bleeding signs, antiplatelet review, and teaching that platelet count supplements โ€” not replaces โ€” clinical judgment.

Before the Test
โœ“Confirm platelet count or CBC order and stat timing
โœ“Baseline petechiae, gum bleeding, procedure plans, and antiplatelet or anticoagulant medicines
โœ“Review chemotherapy, heparin, and medicines affecting marrow or clotting
โœ“Prepare lavender EDTA tube and transport logistics
During the Test
โœ“Collect EDTA whole blood per venipuncture policy; gentle mix per laboratory protocol
โœ“Monitor for vasovagal symptoms during venipuncture
โœ“Transport without avoidable delay per laboratory protocol
After the Test
โœ“Report results with focused bleeding assessment โ€” not the number alone
โœ“Trend PLT with hemoglobin, medicines, transfusion, and symptom recovery
โœ“Evaluate outcomes after platelet transfusion or hold orders โ€” bleeding signs trump modest PLT improvement
โœ“Reinforce when to report gum bleeding, nosebleeds, or petechiae despite improving platelet trend

Documentation

Documentation should link platelet results to bleeding assessment, medicines, and communication.

Example Nursing Note

“Platelet count collected 09:15 on oncology day 12. Pre-draw: petechiae on forearms, gum bleeding when brushing, aspirin 81 mg on MAR. PLT fell from 48 x10^9/L to 22 x10^9/L (critical per facility policy). Prescriber notified 09:22 with symptom summary and read-back โ€” bleeding precautions implemented; aspirin held per order. Repeat platelet count in 6 hours ordered; evaluate outcomes with trend and mucosal bleeding reassessment.”

Key Documentation Points
  • Collection time and EDTA tube verification
  • Petechiae, gum bleeding, medicines reviewed, and procedure plans
  • Prior PLT trend and parallel CBC components
  • Prescriber notification and read-back for critical or discordant results
  • Bleeding precautions, transfusion, or hold response with follow-up plan
  • Patient teaching on report-now bleeding symptoms

Patient and Family Education

Use plain language connecting symptoms with test purpose and follow-up.

โœ“Explain platelets are clotting cells counted with other blood tests, often on a CBC
โœ“Clarify that special preparation is usually not required for platelet count alone
โœ“Teach which symptoms to report (petechiae, gum or nose bleeding, blood in stool or urine)
โœ“Emphasize not stopping aspirin or other medicines unless the clinician instructs
โœ“Describe that doctors may repeat platelet count to monitor chemotherapy or bleeding risk
โœ“Confirm follow-up plans and when to seek urgent review per facility guidance
๐Ÿ“š

Platelet Count NCLEX practice questions

Practice NCLEX-style clinical judgment focused on Platelet Count safety and nursing judgment. Use the case tabs (orders, results, assessment, nursing notes), then answer eight Next Genโ€“style items (including an ordered workflow step) and evaluate outcomes with the answer key.

Select a tab to view orders, results, assessment, and nursing note details for this case.

  • Order: Platelet count stat โ€” oncology inpatient unit
  • Indication: 62-year-old on chemotherapy with falling platelets, petechiae, and gum bleeding
  • Timing: Platelet count drawn this morning; prior PLT 48 x10^9/L yesterday
  • Related orders: Platelet count 22 x10^9/L (critical per policy); aspirin 81 mg on MAR; repeat count in 6 hours ordered
Question 1 โ€” Priority action

After reviewing the case tabs, what is the nurse’s priority action?

Question 2 โ€” Recognize cues

Which findings from the case tabs require clarification or escalation before routine monitoring only? Select all that apply

Question 3 โ€” Trend interpretation

Which trends or events should the nurse recognize as concerning in this platelet workup?

Trend snapshot
Platelets fell from 48 x10^9/L to 22 x10^9/L in 24 hours; reports gum bleeding and new petechiae

Select all that apply

Question 4 โ€” Matrix judgment

Classify each finding for this patient:

Finding Expected โ€” document and continue monitoring Requires follow-up โ€” notify team / repeat test Urgent โ€” immediate escalation
Prior platelet count yesterday 48 x10^9/L without bleeding โ€” historical context only
Platelets 22 x10^9/L critical with gum bleeding while repeat count is pending
Platelets 22 x10^9/L with uncontrolled oral hemorrhage and hypotension
Patient reassured that improving platelets tomorrow eliminates all bleeding precautions

On a small screen, swipe or scroll sideways to see the full table.

Question 5 โ€” Clinical judgment

The patient asks, “Does a low platelet count always mean I need a transfusion today?” What is the best nursing response?

Question 6 โ€” Documentation (cloze)

Complete the priority documentation after stat platelet collection in suspected thrombocytopenia with bleeding:

The highest-priority documentation action is .

Question 7 โ€” Workflow (ordered response)

After critical thrombocytopenia with gum bleeding is reported on a standalone platelet count, rank nursing actions (1 = first).

  1. Document critical value, bleeding assessment, read-back, and precautions in the chart
  2. Notify prescriber with critical platelet value; initiate critical-value protocol and bleeding precautions
  3. Assess gum bleeding, petechiae, blood pressure, and perfusion; hold antiplatelet agents per order
  4. Reassess the patient, verify the order and identity, and prepare for prescriber follow-up
Question 8 โ€” Evaluate outcomes

Repeat platelet count six hours later shows 28 x10^9/L (up from 22K) with no new bleeding and stable blood pressure. What outcome best shows safe follow-through?

Answer key & rationale

Frequently Asked Questions

FAQ

What does a platelet count blood test measure?

a platelet count measures the number of platelets in a blood sample โ€” small cell fragments that help blood clot and stop bleeding.

Does the patient need to fast before a platelet count test?

Usually not for platelet count alone. If your provider ordered additional blood tests on the same sample, you may need to fast โ€” follow local laboratory instructions.

What does a low platelet count mean?

A lower-than-normal count is called thrombocytopenia โ€” it may increase bleeding risk and requires interpretation with symptoms, medicines, and other tests.

Can EDTA tubes cause a falsely low platelet count?

Yes. Pseudothrombocytopenia from EDTA-induced platelet clumping can spuriously lower the automated count โ€” the laboratory may review a peripheral smear or recollect in another tube.

Do reference ranges vary between laboratories?

Yes. Reference intervals are an example adult interval of 150,000 to 400,000 platelets per microliter, but ranges vary by laboratory method. Always use the interval on the patient’s report.

When should nurses escalate despite a modestly improving platelet count?

Escalate when gum bleeding, petechiae, hypotension, or uncontrolled hemorrhage persist. Evaluate outcomes with repeat counts and examination, not PLT trend alone after transfusion.

What related tests are often ordered with platelet count?

platelet count is often part of a complete blood count with hemoglobin and white cell counts โ€” peripheral smear review may follow abnormal results.

References

References
  1. MedlinePlus. Platelet Count. U.S. National Library of Medicine.
    https://medlineplus.gov/lab-tests/platelet-count/
  2. MedlinePlus. Platelet Count. Medical Encyclopedia. U.S. National Library of Medicine.
    https://medlineplus.gov/ency/article/003647.htm
  3. MedlinePlus. Complete Blood Count (CBC). U.S. National Library of Medicine.
    https://medlineplus.gov/lab-tests/complete-blood-count-cbc/
  4. American Society of Hematology. Blood Basics. ASH.
    https://www.hematology.org/education/patients/blood-basics
  5. Kessler CM, Khanani MM. Thrombocytopenia. StatPearls.
    https://www.ncbi.nlm.nih.gov/books/NBK537252/
  6. MedlinePlus. Platelet Tests. U.S. National Library of Medicine.
    https://medlineplus.gov/lab-tests/platelet-tests/
  7. National Heart, Lung, and Blood Institute. What Are Platelets?. U.S. Department of Health and Human Services.
    https://www.nhlbi.nih.gov/health/platelets
  8. Kessler CM, Khanani MM. Thrombocytosis. StatPearls.
    https://www.ncbi.nlm.nih.gov/books/NBK557792/

Editorial Standards & Medical Review

About the author: Sid A. Abdala Balal, RN, writes evidence-based nursing education focused on diagnostic safety, clinical interpretation, and bedside nursing judgment.

Medical review: This guide is reviewed by Dr. Adam Sayedi, MD, for clinical accuracy, diagnostic safety, and alignment with current standards for Platelet Count.

Policies: Medical Review Process ยท Editorial Policy ยท Correction Policy